IKON Group Investments — Global Holdings Company

IKON Market Brief: Omada Health appoints Wei-Li Shao as new CEO as company ramps up GLP-1 strategy

Posted by:

|

On:

|

Omada Health reported strong Q2 growth driven by demand for its integrated approach to managing chronic conditions such as diabetes, hypertension, obesity and musculoskeletal disorders.

Source: www.fiercehealthcare.com

IKON Portfolio Context

Our healthcare vertical includes Renew Republic Health (precision medicine, TRT, peptide therapy) and Renew Lab Group (pharmaceutical testing), both headquartered in Houston, Texas.

Posted by

in